Evolus Inc is getting support for its legal battle withย AbbVie Incโ€™sย Allerganย over a rival to the Botox wrinkle treatment from dermatologists tired of an โ€œ800-pound gorillaโ€ controlling the beauty market.

More than four dozen dermatologists have written to the U.S. International Trade Commission, asking it to allow Botox rival Jeuveau to stay on the US market. A trade judge in July recommended a 10-year ban on imports of Korean-made Jeuveau, saying it was created using a stolen formula.

Read the full article at bloomberg.com